Truncated EphA2 likely potentiates cell adhesion via integrins as well as infiltration and/or lodgment of a monocyte/macrophage cell line in the red pulp and marginal zone of the mouse spleen, where ephrin-A1 is prominently expressed in the vasculature.
We previously established a J774.1 monocyte/macrophage subline expressing a truncated EphA2 construct lacking the kinase domain. We demonstrated that following ephrin-A1 stimulation, endogenous EphA2 promotes cell adhesion through interaction with integrins and integrin ligands such as ICAM1 and that truncated EphA2 potentiates the adhesion and becomes associated with the integrin/integrin ligand complex. Based on these findings, we hypothesized that the EphA/ephrin-A system, particularly EphA2/ephrin-A1, regulates transendothelial migration/tissue infiltration of monocytes/macrophages, because ephrin-A1 is widely recognized to be upregulated in inflammatory vasculatures. To evaluate whether this hypothesis is applicable in the spleen, we screened for EphA2/ephrin-A1 expression and reexamined the cellular properties of the J774.1 subline. We found that ephrin-A1 was expressed in the vasculature of the marginal zone and the red pulp and that its expression was upregulated in response to phagocyte depletion; further, CD115, F4/80, and CXCR4 were expressed in J774.1 cells, which serve as a usable substitute for monocytes/macrophages. Moreover, following ephrin-A1 stimulation, truncated EphA2 did not detectably interfere with the phosphorylation of endogenous EphA2, and it potentiated cell adhesion possibly through modulation of integrin avidity. Accordingly, by intravenously injecting mice with equal numbers of J774.1 and the subline cells labeled with distinct fluorochromes, we determined that truncated EphA2 markedly potentiated preferential cell infiltration into the red pulp and the marginal zone. Thus, modulation of EphA2 signaling might contribute to effective transplantation of tissue-specific resident macrophages and/or monocytes.
Laboratory of Veterinary Anatomy, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-Ourai-Kita, Izumisano, Osaka, 598-8531, Japan.
Naoko
N
Konda
Laboratory of Veterinary Anatomy, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-Ourai-Kita, Izumisano, Osaka, 598-8531, Japan.
Noritaka
N
Saeki
Laboratory of Veterinary Anatomy, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-Ourai-Kita, Izumisano, Osaka, 598-8531, Japan.
Shingo
S
Nishino
Laboratory of Veterinary Anatomy, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1-58 Rinku-Ourai-Kita, Izumisano, Osaka, 598-8531, Japan. kogawa@vet.osakafu-u.ac.jp.
Kazushige
http://orcid.org/0000-0003-1479-8706
K
Ogawa
D000818:Animals; D002448:Cell Adhesion; D002460:Cell Line; D036382:Ephrin-A1 / Q000378:metabolism*; D016023:Integrins / Q000378:metabolism*; D008264:Macrophages / Q000166:cytology* / Q000378:metabolism; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009000:Monocytes / Q000166:cytology* / Q000378:metabolism; D036104:Receptor, EphA2 / Q000378:metabolism*; D013154:Spleen / Q000098:blood supply* / Q000166:cytology*
D036382:Ephrin-A1; D016023:Integrins; D036104:Receptor, EphA2
Adhesion; EphA2; Ephrin-A1; Infiltration; Spleen
Nat Rev Mol Cell Biol. 2016 Apr;17(4):240-56
26790531
Histochem Cell Biol. 2011 Dec;136(6):617-36
21959989
Histochem Cell Biol. 2013 Dec;140(6):659-75
23881165
J Cell Sci. 2006 Feb 1;119(Pt 3):559-70
16443753
Nature. 2015 Nov 26;527(7579):466-471
26570997
J Immunol. 2011 Mar 15;186(6):3441-51
21307289
Science. 2010 Feb 5;327(5966):656-61
20133564
Nat Rev Immunol. 2005 Aug;5(8):606-16
16056254
Immunity. 2014 Nov 20;41(5):694-707
25517612
J Vasc Surg. 2007 Jun;45 Suppl A:A48-56
17544024
Eur J Immunol. 2005 Mar;35(3):699-708
15714584
Science. 2009 Jul 31;325(5940):612-6
19644120
Science. 2013 Nov 22;342(6161):1242974
24264994
Biochimie. 1998 Feb;80(2):173-95
9587675
J Exp Med. 2001 Jul 2;194(1):45-56
11435471
Nat Rev Cancer. 2010 Mar;10(3):165-80
20179713
J Exp Med. 1999 Feb 1;189(3):451-60
9927507
Genome Biol. 2007;8(5):215
17543136
Nat Rev Immunol. 2011 Jun;11(6):416-26
21597477
J Clin Invest. 2011 May;121(5):1969-73
21490397
Cell. 2008 Apr 4;133(1):38-52
18394988
Cell. 1999 Oct 1;99(1):23-33
10520991
Oncogene. 2000 Dec 7;19(52):6043-52
11146556
Science. 1995 Apr 28;268(5210):567-9
7536959
J Immunol. 2003 Aug 1;171(3):1148-55
12874200
Blood. 2011 May 19;117(20):5403-12
21444914
Pathology. 2013 Jun;45(4):408-16
23619587
Nat Immunol. 2013 Oct;14(10):986-95
24048120
J Int Med Res. 2011;39(2):522-7
21672356
Nature. 2000 Jul 20;406(6793):309-14
10917533
Nat Rev Immunol. 2007 Sep;7(9):678-89
17717539
Cell Adh Migr. 2015;9(6):469-82
26565750
Nat Rev Mol Cell Biol. 2005 Jun;6(6):462-75
15928710
Annu Rev Immunol. 2007;25:619-47
17201681
Mol Immunol. 2008 Mar;45(5):1208-20
17980912
Nature. 2014 Oct 23;514(7523):450-4
25274301
Int J Hematol. 2016 Feb;103(2):145-54
26475284
Microbiol Immunol. 2015 Feb;59(2):55-62
25611090
Nat Rev Immunol. 2009 Sep;9(9):618-29
19644499
Cell Mol Life Sci. 2014 Oct;71(19):3685-710
24794629
Am J Pathol. 2012 Nov;181(5):1493-503
23021982
Front Immunol. 2015 Jun 26;6:333
26167166
J Exp Med. 1999 Jan 18;189(2):403-12
9892622